Royal Bank Of Canada Bausch Health Companies Inc. Call Options Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Nov 05, 2024	BUY	$7.77 - $10.61 $1.71 Million - $2.33 Million	220,000 New	220,000 $2.33 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $1.71 Million - $2.33 Million	220,000 New	220,000 $2.33 Million
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $229,000 - $460,500	-50,000 Reduced 18.52%	220,000 $1.52 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $1.13 Million - $3.78 Million	160,000 Added 145.45%	270,000 $2.26 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $1.4 Million - $1.81 Million	65,000 Added 144.44%	110,000 $2.51 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $1.13 Million - $1.35 Million	45,000 New	45,000 $1.25 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.78B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.